Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases
Eléonore Beurel
Frontiers in Molecular Neuroscience (2011) Vol. 4
Open Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases
Teresa Gianferrara, Eleonora Cescon, Ilenia Grieco, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 27, pp. 4631-4697
Closed Access | Times Cited: 30
The role of glycogen synthase kinase 3 beta in neurodegenerative diseases
Honglu Yu, Min Xiong, Zhentao Zhang
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 20
Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease
Suggala Ramya Shri, Suman Manandhar, Yogendra Nayak, et al.
Advanced Pharmaceutical Bulletin (2023) Vol. 13, Iss. 4, pp. 688-700
Open Access | Times Cited: 18
Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: Impact of mouse models
Tatiana V. Lipina, John Roder
Neuroscience & Biobehavioral Reviews (2014) Vol. 45, pp. 271-294
Closed Access | Times Cited: 52
Insight into glycogen synthase kinase-3β inhibitory activity of phyto-constituents from Melissa officinalis: in silico studies
Opeyemi Iwaloye, Olusola Olalekan Elekofehinti, Emmanuel A. Oluwarotimi, et al.
In Silico Pharmacology (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 45
Tissue and circulating microRNAs as biomarkers of response to obesity treatment strategies
Giuseppina Catanzaro, Tiziana Filardi, Claudia Sabato, et al.
Journal of Endocrinological Investigation (2020) Vol. 44, Iss. 6, pp. 1159-1174
Open Access | Times Cited: 40
Mechanisms and Therapeutic Targets of Depression After Intracerebral Hemorrhage
Yinan Wu, Liangliang Wang, Kaimin Hu, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 44
Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder
Qingzhong Wang, Yogesh Dwivedi
The World Journal of Biological Psychiatry (2016) Vol. 18, Iss. 8, pp. 592-603
Open Access | Times Cited: 40
The role of glycogen synthase kinase 3 beta in multiple sclerosis
Tayebeh Noori, Ahmad Reza Dehpour, Antoni Sureda, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110874-110874
Open Access | Times Cited: 38
Molecular Biology of Atherosclerotic Ischemic Strokes
Antonino Tuttolomondo, Maria Grazia Puleo, Maria Chiara Velardo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9372-9372
Open Access | Times Cited: 34
Extracellular Vesicle Proteins and MicroRNAs Are Linked to Chronic Post-Traumatic Stress Disorder Symptoms in Service Members and Veterans With Mild Traumatic Brain Injury
Vivian A. Guedes, Chen Lai, Christina Devoto, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32
The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases
Gerwyn Morris, Ken Walder, André F. Carvalho, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 84, pp. 453-469
Closed Access | Times Cited: 36
Chronic over-nutrition and dysregulation of GSK3 in diseases
Xunxian Liu, Zemin Yao
Nutrition & Metabolism (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 32
Anti-inflammatory effects of lipoic acid through inhibition of GSK-3β in lipopolysaccharide-induced BV-2 microglial cells
Yoshiki Koriyama, Y. Nakayama, Seiichi Matsugo, et al.
Neuroscience Research (2013) Vol. 77, Iss. 1-2, pp. 87-96
Open Access | Times Cited: 32
sVCAM-1, sICAM-1, TNF-α and IL-6 levels in bipolar disorder type I: Acute, longitudinal and therapeutic implications
Maja Pantović-Stefanović, Nataša Petronijević, Bojana Dunjic-Kostić, et al.
The World Journal of Biological Psychiatry (2016) Vol. 19, Iss. sup2, pp. S41-S51
Closed Access | Times Cited: 30
Neuroprotective effects of valproic acid on brain ischemia are related to its HDAC and GSK3 inhibitions
Monalisa Ribeiro Silva, Alyne Oliveira Correia, Gabriel Cabral Alencar dos Santos, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 167, pp. 17-28
Closed Access | Times Cited: 28
Glycogen synthase kinase-3β inhibition enhances myelination in preterm newborns with intraventricular hemorrhage, but not recombinant Wnt3A
Preeti Dohare, Bokun Cheng, Ehsan Ahmed, et al.
Neurobiology of Disease (2018) Vol. 118, pp. 22-39
Open Access | Times Cited: 28
Chrysin suppress immune responses and protects from experimental autoimmune encephalomyelitis in mice
Lucian Del Fabbro, Marcelo Gomes de Gomes, Leandro Cattelan Souza, et al.
Journal of Neuroimmunology (2019) Vol. 335, pp. 577007-577007
Open Access | Times Cited: 27
let-7g counteracts endothelial dysfunction and ameliorating neurological functions in mouse ischemia/reperfusion stroke model
David L. Bernstein, Sachin Gajghate, Nancy L. Reichenbach, et al.
Brain Behavior and Immunity (2020) Vol. 87, pp. 543-555
Open Access | Times Cited: 27
Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer’s disease
Xueyang Jiang, Junting Zhou, Yang Wang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112751-112751
Closed Access | Times Cited: 27
Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer’s disease
Xueyang Jiang, Yang Wang, Chang Liu, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 30, pp. 115940-115940
Closed Access | Times Cited: 27
Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia
Maja Pantović-Stefanović, Nataša Petronijević, Bojana Dunjic-Kostić, et al.
Journal of Psychiatric Research (2015) Vol. 73, pp. 45-52
Closed Access | Times Cited: 28
Therapeutic concentration of lithium stimulates complement C3 production in dendritic cells and microglia via GSK‐3 inhibition
Zhiqian Yu, Chiaki Ono, Setsuya Aiba, et al.
Glia (2014) Vol. 63, Iss. 2, pp. 257-270
Closed Access | Times Cited: 26
Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential
Jonathan Martin Flintoff, James P. Kesby, Dan Siskind, et al.
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 8, pp. 877-891
Closed Access | Times Cited: 18
Atorvastatin Promotes Pro/anti-inflammatory Phenotypic Transformation of Microglia via Wnt/β-catenin Pathway in Hypoxic-Ischemic Neonatal Rats
Luting Yu, Lingyi Huang, Yuanyuan Zhao, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 6, pp. 3559-3577
Open Access | Times Cited: 7

Scroll to top